Probiotics - the nano soldiers of oral health

Journal, Indian Academy of Clinical Medicine

Volumn 13, Issue 1, 2012, Pages 48-54

  Grover, Harpreet Singh ^a   Luthra, Shailly ^a  

^a SGT UNIVERSITY   (India)

Author keywords

Bifidobacterium; Lactobacillus; Oral health; Probiotics

Indexed keywords

BILE SALT; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; LACTIC ACID; LACTULOSE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VITAMIN B GROUP; VITAMIN K GROUP;

ACTINOMYCES; ADAPTIVE IMMUNITY; ALCOHOL LIVER DISEASE; ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; ASTHMA; BACILLUS CEREUS; BACTEREMIA; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CANDIDA ALBICANS; CARBOHYDRATE METABOLISM; DENTAL CARIES; DENTAL HEALTH; DIET SUPPLEMENTATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME SYNTHESIS; EPITHELIUM CELL; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; GROWTH INHIBITION; HEALTH PROMOTION; HELICOBACTER INFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOMODULATION; INFECTION RISK; INNATE IMMUNITY; INTESTINE FLORA; JUVENILE RHEUMATOID ARTHRITIS; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOSE INTOLERANCE; MICROBIAL COLONIZATION; MILK ALLERGY; MOUTH CAVITY; MOUTH FLORA; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROPIONIBACTERIUM; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW; SACCHAROMYCES BOULARDII; SEPSIS; STREPTOCOCCUS THERMOPHILUS; TOOTH PLAQUE; ULCERATIVE COLITIS; UROGENITAL TRACT INFECTION;

EID: 84861644965     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Metchnikoff E. The prolongation of life. Optimistic studies NewYork: Putman's Sons; 1908; p.161-183.
2. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science 1965; 147: 747-8.
3. Elisa KB, Scott BS. Regulatory T-cells in inflammatory bowel disease. Curr Opin Gastroenterol 2008; 24 (6): 733-41.
4. Ashwell M. Concept of functional foods 2002. ILSI; (International Life Sciences Institute) Europe: B-1200 Brussels, Belgium ISBN 1-57881-145-7.
5. Marteau P, Cuillerier E, Meance S et al. Bifidobacteriumanimalisstrain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomised, controlled study. Aliment Pharmacol Ther 2002; 16 (3): 587-93.
6. Suvarna VC, Boby VG. Probiotics in human health. A current assessment. Current Science 2005; 88:1744-8.
7. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect 2005;11 (12): 958-66.
8. Santosa S, Farnworth E, Jones PJ. Probiotics and their potential health claims. Nutr Rev 2006; 64 (6): 265-74.
9. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006; 4 (2): 261-75.
10. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? EurJOral Sci 2005; 113 (3): 188-96.
11. Galdeano CM, de Moreno de Le Blanc A, Vinderola G et al. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine lmmunol 2007; 14 (5): 485-92.
12. deRoos NM, Katan MB. Effects of probiotic bacteria on diarrhoea, lipid metabolism,and carcinogenesis:a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71 (2):405-11.
13. Oyetayo VO, Oyetayo FL. Potential of probiotics as biotherapeutic agents targeting the innate immune system. African Journal of Biotechnology 2005; 4 (2): 123-7.
14. Agarwal E, Bajaj P, Guruprasad CN et al. Probiotics: A Novel Step Towards Oral Health. AOSR 2011;1 (2): 108-15.
15. Sanders ME. Considerations for Use of Probiotic Bacteria to Modulate Human. Health J Nutr 2000;130 (2S Suppl): 384S-390S.
16. Huovinen P. Bacteriotherapy, the time has come. BMJ 2001; 323 (7309): 353-4.
17. Salminen MK, Tynkkynen S, Rautelin H et al. Lactobacillus bacteraemia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35 (10): 1155-60. Epub 2002 Oct 21.
18. Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral Dis 2007; 13 (5): 443-51.
19. Ostengo Mdel C, Elena Nader-Macías M. Hydroxylapatite beads as an experimental model to study the adhesion of lactic acid bacteria from the oral cavity to hard tissues. Methods Mol Biol 2004; 268: 447-52.
20. Kang MS, Na HS, Oh JS. Coaggregation ability of Weissella cibaria isolates with Fusobacterium nucleatum and their adhesiveness to epithelial cells. FEMS Microbiol Lett 2005; 253 (2): 323-9. Epub 2005 Oct 21.
21. Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 2000; 54: 413-37.
22. Boris S, Suárez JE, Barbés C. Characterisation of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J Appl Microbiol 1997; 83 (4): 413-20.
23. Haukioja A, Yli-Knuuttila H, Loimaranta V et al. Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. OralMicrobiol Immunol 2006; 21 (5):326-32.
24. Krasse P, Carlsson B, Dahl C et al. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006; 30 (2): 55-60.
25. Kõll-Klais P, Mändar R, Leibur E et al. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005; 20 (6): 354-61.
26. Volozhin Al, Il'in VK, Maksimovski-lu M et al. [Development and use of periodontal dressing of collagen and Lactobacillus casei 37 cell suspension in combined treatment of periodontal disease of inflammatory origin (a microbiological study)]. Stomatologiia (Mosk) 2004; 83 (6): 6-8.
27. Grudianov Al, Dmitrieva NA, Fomenko EV. Use of probiotics Bifidumbacterin and Acilact in tablets in therapy of periodontal inflammations. Stomatoloaiia (Mosk) 2002; 81 (1): 39-43.
28. Al-Zahrani MS. Increased intake of dairy products is related to lower periodontitis prevalence. J Periodontol 2006; 77 (2): 289-94.
29. Shimazaki Y, Shirota T, Uchida K et al. Intake of dairy products and periodontal disease:the Hisayama Study. J Periodontol 2008; 79 (1): 131-7.
30. Shimauchi H, Mayanagi G, Nakaya S et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21:a randomised,double-blind, placebo-controlled study. J Clin Periodontol 2008; 35 (10): 897-905. Epub 2008 Aug 24.
31. Teughels W, Newman MG, Coucke W et al. Guiding periodontal pocket recolonisation: a proof of concept. J Dent Res 2007; 86 (11): 1078-82.
32. Burton JP, Chilcott CN, Moore CJ et al. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 2006; 100 (4): 754-764.
33. Elahi S, Pang G, Ashman R, Clancy R. Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus. Acidophilus 2005; 141 (1): 29-36.
34. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: What are the risks? Am J Clin Nutr 2006; 83 (6): 1256-64; quiz 1446-7
35. Borriello SP, Hammes WP, Holzapfel W et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36 (6): 775-80. Epub 2003 Mar 5.
36. Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus:a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005; 24 (1): 31-40.